|
1
|
Nakeeb A: Sphincter of Oddi dysfunction:
How is it diagnosed? How is it classified? How do we treat it
medically, endoscopically, and surgically? J Gastrointest Surg.
17:1557–1558. 2013.
|
|
2
|
Capodicasa E: Ruggero Oddi: 120 years
after the description of the eponymous sphincter: A story to be
remembered. J Gastroenterol Hepatolo. 23:1200–1203. 2008.
View Article : Google Scholar
|
|
3
|
Wang F, Wang CM, Liu JD and Wang YT:
Influence of paeoniflorin on intracellular calcium ion
concentration in the sphincter of Oddi of hypercholesterolemic
rabbits. Genet Mol Res. 13:5001–5010. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vitton V, Ezzedine S, Gonzalez JM, Gasmi
M, Grimaud JC and Barthet M: Medical treatment for sphincter of
Oddi dysfunction: Can it replace endoscopic sphincterotomy? World J
Gastroenterol. 18:1610–1615. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rehman A, Affronti J and Rao S: Sphincter
of Oddi dysfunction: An evidence-based review. Gastroenterol
Hepatol. 7:713–722. 2013.
|
|
6
|
Li Y, He Y, Zhou Y and Chen X: Endoscopic
sphincterotomy for sphincter of Oddi dysfunction. China Journal of
Endoscopy. 1:108–110. 2002.
|
|
7
|
Wei JG, Wang YC, Du F and Yu HJ: Dynamic
and ultrastructural study of sphincter of Oddi in early-stage
cholelithiasis in rabbits with hypercholesterolemia. World J
Gastroenterol. 6:102–106. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
He W: Study on the mechanism of Peony and
Licorice Decoction to relieving pain. J North Pharmacy.
10:1012013.
|
|
9
|
Yu WS, Ma T, Liu J and Qi QH: Research on
the Effects and Ion Mechenism of paeoniflorin in regulating
Gastrointestinal Motility. Basic Med Sci Clin. 23:1112003.
|
|
10
|
Luo JR, Wang CM, Fu L and Sun YP: Effects
of paeoniflorin on contractile activity of rabbit sphincter of Oddi
muscle rings in vitro. J Dalian Med Univ. 31:668–671. 2009.
|
|
11
|
Ma H, Groth RD, Wheeler DG, Barrett CF and
Tsien RW: Excitation-transcription coupling in sympathetic neurons
and the molecular mechanism of its initiation. Neurosci Res.
70:2–8. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Moosmang S, Kleppisch T, Wegener J,
Welling A and Hofmann F: Analysis of calcium channels by
conditional mutagenesis. Handb Exp Pharmacol. 178:469–490. 2007.
View Article : Google Scholar
|
|
13
|
Hill-Eubanks DC, Werner ME, Heppner TJ and
Nelson MT: Calcium signaling in smooth muscle. Cold Spring Harb
Perspect Biol. 3:a0045492011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang H and Stephens NL: Calcium and
smooth muscle contraction. Mol Cell Biophys. 135:1–9. 1994.
|
|
15
|
Dimopoulos GJ, Semba S, Kitazawa K, Eto M
and Kitazawa T: Ca 2+ -dependent rapid Ca 2+ sensitization of
contraction in arterial smooth muscle. Circ Res. 100:121–129. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Catterall WA: Voltage-gated calcium
channels. Cold Spring Harb Perspect Biol. 3:a0039472011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lasson A: The postcholecystectomy
syndrome: Diagnostic and therapeutic strategy. Scand J
Gastroenterol. 22:897–902. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rowan AN: People for the Ethical Treatment
of Animals v. Institutional Animal Care and Use Committee of the
University of Oregon. Zoologica Africana. 21:89–94. 1986.
|
|
19
|
Hollands C: The Animals (Scientific
Procedures) Act 1986. The Lancet. 328:32–33. 1986. View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu ZY, Lin PT, Liu J and Liao DQ:
Remifentanil induces l-type ca 2+, channel inhibition in human
mesenteric arterial smooth muscle cells. Can J Anaesth. 55:238–244.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Szilvássy Z, Nagy I, Madácsy L, Hajnal F,
Velösy B, Takács T and Lonovics J: Beneficial effect of lovastatin
on sphincter of Oddi dyskinesia in hypercholesterolemia and
hypertriglyceridemia. Am J Gastroenterol. 92:900–902.
1997.PubMed/NCBI
|
|
23
|
Takao Y, Takaoka Y, Sugano A, Sato H,
Motoyama Y, Ohta M, Nishimoto T and Mizobuchi S: Shakuyaku-kanzo-to
(Shao-Yao-Gan-Cao-Tang) as treatment of painful muscle cramps in
patients with lumbar spinal stenosis and its minimum effective
dose. Kobe J Med Sci. 61:E132–E137. 2016.
|
|
24
|
Song R, Wang CM, Xue WB and Ji XH:
Preparation of serum containing drugs of Shaoyao Gancao Decoction
and its effect on intracellular Ca2+ concentration of sphincter of
Oddi in rabbits of hypercholesterolemic. Chinese Archives of
Traditional Chinese Medicine. 11:2612–2615. 2014.(In Chinese).
|
|
25
|
Wang F, Luo JR and Wang CM: Effects of
paeoniflorin on the sphincter of Oddi rings of hypercholesterolemia
rabbits in vitro. China Health Care Nutrition. 24:456–457.
2014.
|
|
26
|
Quan X, Luo H, Liu Y, Xia H, Chen W and
Tang Q: Hydrogen sulfide regulates the colonic motility by
inhibiting both L-type calcium channels and BKCa channels in smooth
muscle cells of rat colon. PLoS One. 10:e01213312015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pallone TL, Khurana S and Cao C:
Voltage-Gated Calcium Channels: Structure and Function (CACNA) In
Encyclopedia of Signaling Molecules. Choi S: Springer; Cham:
2018
|
|
28
|
Catterall WA: Structure and regulation of
voltage-gated Ca2+ channels. Annu Rev Cell Dev Biol. 16:521–555.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hofmann F, Biel M and Flockerzi V:
Molecular basis for Ca2+ channel diversity. Annu Rev Neurosci.
17:399–418. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ertel EA, Campbell KP, Harpold MM, Hofmann
F, Mori Y, Perez-Reyes E, Schwartz A, Snutch TP, Tanabe T,
Birnbaumer L, et al: Nomenclature of voltage-gated calcium
channels. Neuron. 25:533–535. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Takahashi Y, Jeong SY, Ogata K, Goto J,
Hashida H, Isahara K and Kanazawa I: Human skeletal muscle calcium
channel alpha1S is expressed in the basal ganglia: Distinctive
expression pattern among L-type Ca2+ channels. Neurosci Res.
45:129–137. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Moosmang S, Schulla V, Welling A, Feil R,
Feil S, Wegener JW, Hofmann F and Klugbauer N: Dominant role of
smooth muscle L-type calcium channel Cav1.2 for blood pressure
regulation. EMBO J. 22:6027–6034. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schulla V, Renström E, Feil R, Feil S,
Franklin I, Gjinovci A, Jing XJ, Laux D, Lundquist I, Magnuson MA,
et al: Impaired insulin secretion and glucose tolerance in
beta cell-selective Ca(v)1. 2 Ca2+ channel null mice. EMBO
J. 22:3844–3854. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bock G, Gebhart M, Scharinger A,
Jangsangthong W, Busquet P, Poggiani C, Sartori S, Mangoni ME,
Sinnegger-Brauns MJ, Herzig S, et al: Functional Properties of a
Newly Identified C-terminal Splice Variant, of Cav1.3 L-type Ca2+
Channels. J Biol Chem. 286:42736–42748. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Davies A, Hendrich J, Van Minh AT, Wratten
J, Douglas L and Dolphin AC: Functional biology of the
alpha(2)delta subunits of voltage-gated calcium channels. Trends
Pharmacol Sci. 28:220–228. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dolphin AC: Calcium channel auxiliary α2δ
and β subunits: trafficking and one step beyond. Nat Rev Neurosci.
13:542–555. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dolphin AC: Calcium channel diversity:
multiple roles of calcium channel subunits. Curr Opin Neurobiol.
19:237–244. 2012. View Article : Google Scholar
|
|
38
|
Hofmann F, Flockerzi V, Kahl S and Wegener
JW: L-type CaV1.2 calcium channels: From in vitro findings to in
vivo function. Physiol Rev. 94:303–326. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rosenberg RL, Hess P and Tsien RW: Cardiac
calcium channels in planar lipid bilayers. L-type channels and
calcium-permeable channels open at negative membrane potentials J
Gen Physiol. 92:27–54. 1988.PubMed/NCBI
|
